Table 3. Comparison of clinical backgrounds and ART outcomes between pregnant and nonpregnant patients.
Pregnant (n=21) Nonpregnant (n=13) P
Age (y)
mean (SD) (95% CI)
median (range)
35.6 (±0.77) (34.1-37.1)
36 (29-41)
36.6 (±0.98) (34.2-39)
36 (32-43)
0.45
Previous pregnancies
mean (SD) (95% CI)
median (range)
0.95 (±0.23) (0.47-1.43)
1 (0-3)
1.08 (±0.31) (0.45-1.71)
1 (0-4)
0.74
AMH (ng/mL)
mean (SD) (95% CI)
median (range)
3.53 (±0.61) (2.28-4.78)
2.79 (0.29-11.2)
3.14 (±0.77) (1.55-4.72)
2.12 (0.16-9.22)
0.69
BMI
mean (SD) (95% CI)
median (range)
22.7 (±0.8) (21-24.3)
22.5 (18.9-35.3)
22.2 (±1.02) (20.2-24.5)
21.9 (17.1-28.2)
0.78
Duration of infertility (y)
mean (SD) (95% CI)
median (range)
3.38 (±0.74) (1.86-4.90)
2 (0.5-13)
3.58 (±0.98) (1.57-5.59)
2 (1-12)
0.87
Infertility factor (n)
Fallopian tube factor
Male factor
Endometriosis factor
Diminished ovarian reserve*
5/21 (23.8%)
10/21 (47.6%)
5/21 (23.8%)
7/21 (33.3%)
3/13 (23%)
11/13 (84.6%)
3/13 (23%)
6/13 (46.1%)
1.00
0.06
1.00
0.49
Use of antibiotics (n) 5/21 (23.8%) 5/13 (38.5%) 0.45
Endometrial thickness at embryo transfer (mm)
mean (SD) (95%CI)
median (range)
10.2 (±0.35)
10 (8-14)
10.6 (±0.44)
10 (8-13.1)
0.48
No. of embryos transferred (n)
mean (SD) (95%CI)
median (range)
1.04 (±0.05) (0.94-1.15)
1 (1-2)
1.07 (±0.06) (0.94-1.21)
1 (1-2)
0.73

The clinical background and the number of embryos transferred or the thickness of the endometrium were not significantly different. AMH, anti-Müllerian hormone; ART, assisted reproductive technology; BMI, body mass index; CI, confidence interval; SD, standard deviation
*Diminished ovarian reserve; AMH < 1 ng/mL